Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Antibe Therapeutics Inc (ATBPF)

Antibe Therapeutics Inc (ATBPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Antibe Therapeutics Inc 15 PRINCE ARTHUR AVENUE TORONTO A6 M5R 1B2 CAN

P: 416-922-3460

Description:

Antibe Therapeutics Inc. is a biotech company with a drug platform of therapeutics in pain and inflammation. Its lead drug candidate consists of ATB-346, non-addictive drug for chronic pain and inflammation; ATB-352, for a non-addictive analgesic for treating severe acute pain, while ATB-340 is a GI-safe derivative of aspirin. Antibe Therapeutics Inc. is based in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 28,654
Shares Outstanding, K 52,099
Annual Sales, $ 7,360 K
Annual Net Income, $ -19,930 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,850 K
60-Month Beta 0.29
% of Institutional Shareholders 0.00%
Float, K 52,099
% Float 100.00%

Growth:

1-Year Return -83.38%
3-Year Return -79.05%
5-Year Return -56.00%
5-Year Revenue Growth 117.11%
5-Year Earnings Growth -73.33%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 02/14/22
Next Earnings Date 06/27/22
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr 38.46%
EPS Growth vs. Prev Year 33.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/01/20

ATBPF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.02%
Return-on-Assets % -27.96%
Profit Margin % -270.79
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 4.35
Price/Cash Flow N/A
Price/Book 0.57
Book Value/Share 0.94
Interest Coverage -374.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar